Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76 | 2 | 18 | N/A | 24 |
| Receivables | 8 | 6 | 10 | 10 | 7 |
| Inventories | 70 | 29 | 13 | 31 | 40 |
| TOTAL | $234 | $73 | $82 | $86 | $128 |
| Non-Current Assets | |||||
| PPE Net | 18 | 22 | 25 | 29 | 33 |
| Intangibles | 187 | 236 | 238 | 236 | 233 |
| Other Non-Current Assets | 0 | 35 | 55 | 55 | 55 |
| TOTAL | $205 | $293 | $318 | $320 | $320 |
| Total Assets | $439 | $366 | $400 | $406 | $449 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 60 | 60 | 60 | 58 |
| Accounts payable and accrued liabilities | 1,360 | 1,457 | 1,299 | 1,071 | 961 |
| TOTAL | $2,106 | $1,711 | $1,493 | $1,280 | $1,240 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 300 | 299 | 297 | 153 | 0 |
| TOTAL | $300 | $299 | $297 | $153 | $N/A |
| Total Liabilities | $2,406 | $2,009 | $1,790 | $1,432 | $1,240 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,661 | 28,146 | 28,311 | 28,139 | 28,135 |
| Common Shares | 28 | 28 | 28 | 28 | 28 |
| Retained earnings | -14,473 | -14,040 | -13,751 | -13,350 | -13,077 |
| Other shareholders' equity | -9 | -19 | -30 | -41 | -52 |
| TOTAL | $-1,967 | $-1,644 | $-1,390 | $-1,027 | $-791 |
| Total Liabilities And Equity | $439 | $366 | $400 | $406 | $449 |